1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.76%
Negative 10Y revenue/share CAGR while Consumer Cyclical median is 4.82%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
17.75%
5Y revenue/share growth exceeding 1.5x Consumer Cyclical median of 4.39%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
22.32%
3Y revenue/share growth exceeding 1.5x Consumer Cyclical median of 2.63%. Joel Greenblatt might see a short-term competitive advantage at play.
4159.27%
OCF/share CAGR of 4159.27% while Consumer Cyclical median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
2826.08%
OCF/share CAGR of 2826.08% while Consumer Cyclical median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
12.05%
3Y OCF/share growth of 12.05% while Consumer Cyclical median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
111.82%
Net income/share CAGR exceeding 1.5x Consumer Cyclical median of 27.46% over a decade. Joel Greenblatt might see a standout compounder of earnings.
220.38%
5Y net income/share CAGR > 1.5x Consumer Cyclical median of 16.91%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
566.17%
3Y net income/share CAGR > 1.5x Consumer Cyclical median of 12.52%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
470.39%
3Y dividend/share CAGR of 470.39% while Consumer Cyclical is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.